Possible immunological factors in human malignant melanoma in Uganda.
about
Immunology and cutaneous malignant melanoma.Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cellsFurther characterization of a melanoma-specific protein from human urine.Stimulation of autologous blood lymphocytes by malignant lymphoma cells and homogenates.Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigensThe evolution in melanoma treatment as a reflection of precision-oriented medicine.Studies of humoral and cell-mediated immunity in human melanomaHuman melanoma cells have both nerve growth factor and nerve growth factor-specific receptors on their cell surfaces.Conjunctival melanoma in Southwestern Nigeria: a case series and review of literature.Host responses to malignant disease.Immunologic aspects of melanoma.The immune response in human malignant melanoma.Malignant melanoma: the problem of lymph-node metastases.Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy.Detection of tumor specific immune reactions in human melanoma.Nephrotic syndrome cured by removal of gastric carcinoma.Tumour-specific antibodies in human malignant melanoma and their relationship to the extent of the disease.Halo naevus--a frustrated malignant maelanoma.Fluorescent antibody studies in malignant melanoma.
P2860
Q34079738-72BF1F7B-7423-402D-949E-33ADF4B1D943Q35025264-98C33D21-6B3B-4B4E-9002-23E2FCC6FF7CQ36043973-D6C9C1C4-1B60-4EA9-BC2B-9176FC576C94Q36068882-032223C1-4154-456E-B498-FA9014F92CE1Q36325809-581E63BD-2BE6-4F9E-8401-C30530754E5CQ36359942-C60F9A85-E8F5-46CB-8E8A-9E7B6853A8BAQ36611763-9F264C56-341C-441C-8892-6646EDC5C8AEQ36991945-ACC26C94-DF12-406C-AE27-AA440FD26559Q37320889-9769E9E3-DCF1-4802-B363-45E9AC584E75Q39190872-574C2162-A8F2-43B8-AFEE-80991D105D97Q39905841-BC157085-A37E-4E00-A9C2-407B90D99153Q40132910-5A3C3A73-303C-48FA-892A-FCD0133E636EQ40516623-3704D9E1-F11D-4154-8DCD-97E4ED093B46Q42140843-8A279CC1-0EAF-4072-9410-9245C8E88B15Q46822132-195C7641-B5EA-4384-9E43-CC43E4E44A66Q47731224-36F8777C-16C9-428D-B3E0-871C94790771Q49190598-E2B89281-9957-4725-A640-B6C89143BAB8Q49205029-1879BD50-38EC-4523-86F1-A35CAD0655F3Q49568807-CD5FEFC8-2357-48F9-AE85-379E56A46307Q55487380-CB206213-2687-4F64-8BBE-5D4C1CF14E61
P2860
Possible immunological factors in human malignant melanoma in Uganda.
description
1967 nî lūn-bûn
@nan
1967年の論文
@ja
1967年学术文章
@wuu
1967年学术文章
@zh-cn
1967年学术文章
@zh-hans
1967年学术文章
@zh-my
1967年学术文章
@zh-sg
1967年學術文章
@yue
1967年學術文章
@zh
1967年學術文章
@zh-hant
name
Possible immunological factors in human malignant melanoma in Uganda.
@en
type
label
Possible immunological factors in human malignant melanoma in Uganda.
@en
prefLabel
Possible immunological factors in human malignant melanoma in Uganda.
@en
P1433
P1476
Possible immunological factors in human malignant melanoma in Uganda.
@en
P2093
P304
P356
10.1016/S0140-6736(67)90236-X
P407
P577
1967-10-01T00:00:00Z